4//SEC Filing
Hannan Kathy Hopinkah 4
Accession 0001127602-23-019169
CIK 0001830214other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:05 PM ET
Size
8.3 KB
Accession
0001127602-23-019169
Insider Transaction Report
Form 4
Hannan Kathy Hopinkah
Director
Transactions
- Award
Restricted Stock Units
2023-06-16+105,263→ 105,263 totalExercise: $0.00→ Class A Common Stock (105,263 underlying) - Award
Stock Option
2023-06-16+139,860→ 139,860 totalExercise: $1.90Exp: 2033-06-16→ Class A Common Stock (139,860 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 16, 2024 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. The RSUs have no expiration date. RSUs granted on August 2, 2022 that were initially reported as Class A Common Stock in Table I of a Form 4 dated August 4, 2022 vested in full in shares on June 15, 2023.
- [F3]In accordance with the Issuer's Non-Employee Director Compensation Program, the Black-Scholes value of the option award as of the grant date is $200,000.
Documents
Issuer
Ginkgo Bioworks Holdings, Inc.
CIK 0001830214
Entity typeother
Related Parties
1- filerCIK 0001767813
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:05 PM ET
- Size
- 8.3 KB